Crohn’s Disease

Intestinal Behçet and Crohn’s disease: two sides of the same coin

Behçet’s disease (BD) and Crohn’s disease (CD) are chronic immune-mediated, inflammatory disorders affecting many different systems (joints, skin, eyes,…

Ustekinumab Effective and Safe in Crohn's Colitis

The New England Journal of Medicine has reported the results of a large clinical trial demonstrating the…

Anti-IL-23 Therapy Effective in Crohn's Disease

Lancet has reported the results of risankizumab, an interleukin-23 (IL-23) inhibitor, in Crohn's disease.…

AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease

A Phase 2 study showed upadacitinib significantly reduced patients' intestinal inflammation, results that should push the drug into late-stage testing.


No Comments Yet.

Leave a comment